PL-054

N/A

Report date: 2024/02/29 15:44:13

Base Information

Drug NamePL-054
Drug Alias NamePL054PL-054
ClassificationBiologics
Mechanisms of ActionLipopolysaccharide (LPS) modulatorsMonocyte differentiation antigen CD14 modulators
TargetsLipopolysaccharide (LPS)Monocyte differentiation antigen CD14
Therapy Area/IndicationsInflammationBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZonsen PepLib Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesZonsen PepLib Biotech IncHunan Jiudian Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammationBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A